Enterohepatic circulation of bile acids and their emerging roles on glucolipid metabolism

被引:37
作者
Chen, Meng-jun [1 ]
Liu, Chen [1 ]
Wan, Yue [1 ]
Yang, Lei [1 ]
Jiang, Shu [1 ]
Qian, Da-wei [1 ]
Duan, Jin-ao [1 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, 138 Xianlin Rd, Nanjing 210023, Peoples R China
基金
中国国家自然科学基金;
关键词
Enterohepatic circulation; Bile acids; FXR; TGR5; FARNESOID-X-RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; FIBROBLAST GROWTH FACTOR-19; LOW-DENSITY LIPOPROTEIN; NUCLEAR RECEPTORS; LIPID-METABOLISM; GENE-EXPRESSION; LIVER STEATOSIS; INSULIN SENSITIVITY; TRIGLYCERIDE LEVELS;
D O I
10.1016/j.steroids.2020.108757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bile acids (BAs) are amphiphilic molecules with a nonpolar steroid carbon skeleton and a polar carboxylate side chain. Recently, BAs have aroused the attention of scholars due to their potential roles on metabolic diseases. As important endogenous ligands, BAs are wildly active in the entemhepatic circulation, during which microbiota play a significant role in promoting the hydrolysis and dehydroxylation of BAs. Besides, many pathways initiated by BAs including glucolipid metabolism and inflammation signaling pathways have been reported to regulate the host metabolism and maintain immune homeostasis. Herein, the characteristics on the entemhepatic circulation and metabolism of BAs are systematically summarized. Moreover, the regulation mechanism of the glucolipid metabolism by BAs is intensively discussed. Worthily, FXR and TGR5, which are involved in glucolipid metabolism, are the prime candidates for targeted therapies of chronic metabolic diseases such as diabetes and hypercholestemlemia.
引用
收藏
页数:10
相关论文
共 158 条
[91]   Bile salt transporters [J].
Meier, PJ ;
Stieger, B .
ANNUAL REVIEW OF PHYSIOLOGY, 2002, 64 :635-661
[92]   Antiatherosclerotic effect of farnesoid X receptor [J].
Mencarelli, Andrea ;
Renga, Barbara ;
Distrutti, Eleonora ;
Fiorucci, Stefano .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 296 (02) :H272-H281
[93]   Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System [J].
Mertens, Kim L. ;
Kalsbeek, Andries ;
Soeters, Maarten R. ;
Eggink, Hannah M. .
FRONTIERS IN NEUROSCIENCE, 2017, 11
[94]   E297G mutated bile salt export pump (BSEP) function enhancers derived from GW4064: Structural development study and separation from farnesoid X receptor-agonistic activity [J].
Misawa, Takashi ;
Hayashi, Hisamitsu ;
Makishima, Makoto ;
Sugiyama, Yuichi ;
Hashimoto, Yuichi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) :3962-3966
[95]   Nuclear bile acid receptor FXR as pharmacological target: Are we there yet? [J].
Modica, Salvatore ;
Moschetta, Antonio .
FEBS LETTERS, 2006, 580 (23) :5492-5499
[96]  
Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005
[97]   Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans [J].
Morville, Thomas ;
Sahl, Ronni E. ;
Trammell, Samuel A. J. ;
Svenningsen, Jens S. ;
Gillum, Matthew P. ;
Helge, Jorn W. ;
Clemmensen, Christoffer .
JCI INSIGHT, 2018, 3 (15)
[98]   Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064 [J].
Moscovitz, Jamie E. ;
Kong, Bo ;
Buckley, Kyle ;
Buckley, Brian ;
Guo, Grace L. ;
Aleksunes, Lauren M. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 310 :60-67
[99]   Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial [J].
Oduyebo, Ibironke ;
Camilleri, Michael ;
Nelson, Alfred D. ;
Khemani, Disha ;
Nord, Sara Linker ;
Busciglio, Irene ;
Burton, Duane ;
Rhoten, Deborah ;
Ryks, Michael ;
Carlson, Paula ;
Donato, Leslie ;
Lueke, Alan ;
Kim, Kathline ;
Rossi, Stephen J. ;
Zinsmeister, Alan R. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (05) :725-734
[100]   Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults [J].
Ogawa, Yuji ;
Yoneda, Masato ;
Kobayashi, Takashi ;
Honda, Yasushi ;
Kessoku, Takaomi ;
Imajo, Kento ;
Saito, Satoru ;
Nakajima, Atsushi .
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (01) :69-82